The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Liver and obesity: a narrative review”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Amedeo Lonardo, Ralf Weiskirchen. Tirzepatide in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: a novel star on the horizon?, Exploration of Drug Science. 2025; 3: 1008128. https://doi.org/10.37349/eds.2025.1008128 |
|
2 |
2025 |
Amedeo Lonardo, Ralf Weiskirchen. PPARs in molecular pathogenesis and drug treatment of type 2 diabetes-related MASLD, Exploration of Digestive Diseases. 2025; 4: 100590. https://doi.org/10.37349/edd.2025.100590 |
|
3 |
2025 |
Ralf Weiskirchen, Amedeo Lonardo. Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver Disorders, Medical Sciences. 2025; 13: 265. https://doi.org/10.3390/medsci13040265 |
|
4 |
2026 |
Tianhao Wu, Mingyi Du, Tiejun Zhang, Xingdong Chen, Zhenqiu Liu. Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinoma, Annals of Hepatology. 2026; 31: 102139102139. https://doi.org/10.1016/j.aohep.2025.102139 |